How long have you been with CHASE and what are your responsibilities?
I have been with CHASE since February 2019 and I am managing client relationships to embed our clinical trial patient recruitment services. I will be promoting the value of our patient recruitment solutions to partners and Pharmaceutical companies alike.
What’s your background prior to joining CHASE?
Prior to joining CHASE clinical, I worked as Business Development Director at Parexel. My career spans senior management roles for a variety of major multinational pharmaceutical and healthcare companies. I started my career as a Hospital Pharmacist before joining Eli Lilly in 1997 as a Healthcare Development Manager. From 1999 until 2007, I worked for AstraZeneca in senior roles, including National Sales Management. I then spent 4 years as a clinical Effectiveness Consultant for Pfizer, before becoming NHS Commercial Director for IQVIA between 2012 and 2017.
What do you see as the opportunities for CHASE clinical over the next 5 years?
There are several key challenges with modern clinical studies. Too often feasibility and patient recruitment are not given the focus and resources they deserve. This means trials can underperform due to poor recruitment and site selection or lack of momentum in the local health economy to enrol patients. Delays mean medicines taking longer to reach patients and increased costs. We are a go to provider for feasibility and patient recruitment solutions.
What makes CHASE clinical different to other providers of Patient Recruitment Solutions?
CHASE clinical minimises risk and decreases study costs by deploying flexible clinical research nurse and study facilitator resource that offers timely patient recruitment solutions. CHASE clinical helps you prime your patient recruitment for successand tackles the root causes of delayed clinical trials. We achieve this by using the best research nurses and study facilitators available.Email Andrew Connect on LinkedIn